SG3 Management’s Wave Life Sciences WVE Stock Holding History

SG3 Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-65,000	Closed	-$365K	–	1386
2021 Q1	$365K	Hold	65,000	–	–	0.01%	851
2020 Q4	$512K	Buy	+65,000	New	+$546K	0.01%	725

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG3 Management's WVE Position: Q2 2021 in Review

SG3 Management sold out of Wave Life Sciences (WVE) in Q2 2021, closing a stake of 30,000 shares — an estimated $168K sold.

SG3 Management first reported a position in WVE in Q4 2020 and held it in 2 quarters. The position peaked at $324K in Q4 2020. 87 funds tracked by Wall St. Rank hold WVE as of Q2 2021.

SG3 Management reported no remaining Wave Life Sciences position as of Q2 2021 after selling out during the quarter.
SG3 Management sold 30,000 Wave Life Sciences shares in Q2 2021, an estimated $168K.
SG3 Management first reported a position in Wave Life Sciences in Q4 2020 and held it in 2 quarters.
SG3 Management's Wave Life Sciences position peaked at $324K in Q4 2020.
87 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2021.

Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.